Many studies have shown that the plasma membrane carrier SLC1A5 is overexpressed in several tumors under the control of the c-Myc transcription factor, thus highlighting the important role played by this transporter in enhancing glutamine utilization in order to support cancers’ high proliferative rates [98,99,100,101,102]. This evidence concerns the gene SLC1A5 and cancer.